Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from Operating Activities
Net Loss	$ (16,575,317)	$ (7,390,355)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	720,402	1,549,788
Bad debt expense (recovery)	94,714	(71,003)
Forgiveness of paycheck protection program loan	0	(296,827)
Change in fair market value of warrant liability	(58,276)	(66,862)
Gain on settlement of loan payable	0	(20,000)
Loss on change in fair market value of contingent consideration (Note 2)	240,000	0
Gain on settlement of contingent consideration	(1,700,000)	574,000
Loss on impairment of goodwill and intangible assets	6,993,075	0
Change in reserve for Obsolescence inventory	(52,208)	(140,000)
Amortization of right-of-use asset	1,213,949	635,540
Depreciation and amortization	1,991,798	946,744
Amortization of debt discount	223,643	0
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	19,850	73,189
Cost and estimated earnings excess of billings	(1,125,610)	0
Inventory	(3,633,057)	(166,126)
Vendor deposits	916,494	(951,242)
Prepaid expenses and other current assets	(448,680)	35,273
Income taxes payable	0	(173,716)
Accounts payable and accrued expenses	1,340,655	(361,569)
Billings in excess of costs and earnings on uncompleted contracts	(1,388,838)	0
Deferred revenue	3,941,523	(544,563)
Due to landlord	(279,518)	0
Operating lease payments	(1,170,949)	(630,241)
Net Cash Used in Operating Activities	(8,736,350)	(6,997,970)
Cash Flows From Investing Activities
Cash paid for patent costs	(682)	(14,434)
Purchase of machinery and equipment	(23,017)	(14,735)
Acquisitions, net of cash acquired (Note 2)	(10)	(14,560,193)
Payments on note payable	(152,571)	0
Net Cash Used in Investing Activities	(176,280)	(14,589,362)
Cash Flows From Financing Activities
Payments on financing leases	(6,591)	(7,217)
Proceeds from warrant exercise	0	1,157
Shares repurchased	(149,686)	0
Dividends to preferred shareholders	(1,449,000)	(603,750)
Payments on loan payable	0	(65,000)
Proceeds from equity raises, net	2,021,736	19,272,368
Proceeds from note payable, net	2,462,500	0
Net Cash Provided by Financing Activities	2,878,959	18,597,558
Net Decrease in Cash and equivalents	(6,033,671)	(2,989,774)
Cash, restricted cash, and cash equivalents at January 1,	8,768,156	11,757,930
Cash, restricted cash, and cash equivalents at December 31,	2,734,485	8,768,156
Cash paid during the year for:
Interest	57,534	1,022
Income taxes	0	16,246
Supplemental Schedule of Non-Cash Financing and Investing Activities:
Initial recognition of warrant liability	0	135,125
Property and equipment obtained in exchange for financing lease liabilities	190,702	0
Reclassification from liability to be settled in stock to additional paid in capital	0	21,420
Common stock issued in connection with acquisitions	0	10,195,501
Initial recognition of contingent consideration liability	0	886,000
Recognition of right of use asset - operating lease	3,527,443	1,884,730
Issuance of Note Payable for payment of prepaid expense	$ 318,833	$ 0